Standard Glass Lining Technology IPO Price: ₹133 to ₹140 per share
IPO Dates: 6 January 2025 – 8 January 2025
Company Overview
Incorporated in September 2012, Standard Glass Lining Technology Limited is a prominent manufacturer of specialized engineering equipment catering to the pharmaceutical and chemical industries in India. The company is fully equipped to manage the entire production process in-house, offering a comprehensive suite of services.
Turnkey Solutions for Pharmaceutical and Chemical Industries
The company delivers end-to-end solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for its clients. Its expertise extends across various stages of pharmaceutical and chemical manufacturing processes.
Diverse Product Portfolio
Standard Glass Lining Technology Limited manufactures advanced engineering equipment utilizing glass-lined materials, stainless steel, and nickel alloys. Its product offerings include:
- Reaction Systems
- Storage, Separation, and Drying Systems
- Plant, Engineering, and Services
Esteemed Clientele
The company serves a prestigious client base across the pharmaceutical and chemical sectors, including:
- Pharmaceutical Companies: Aurobindo Pharma Limited, Cadila Pharmaceuticals Limited, Granules India Limited, Laurus Labs Limited, Natco Pharma Limited, MSN Laboratories Private Limited, and Hetero Drugs Limited.
- Chemical Manufacturers: Tagros Chemicals India Private Limited, Deccan Fine Chemicals (India) Private Limited, and others.
Manufacturing and Sales Presence
Standard Glass Lining Technology operates eight manufacturing units located in Hyderabad, Telangana. The company also has sales offices in:
- Vadodara and Ankleshwar, Gujarat
- Mumbai, Maharashtra
- Visakhapatnam, Andhra Pradesh
Its sales team members are strategically positioned in cities such as Jhagadia, Chennai, New Delhi, Bengaluru, and Vijayawada, ensuring a robust pan-India presence.
Competitive Strengths
- Specialized Expertise: Leading manufacturer of specialized engineering equipment for the pharmaceutical and chemical sectors.
- Innovative Offerings: A broad and customizable range of products tailored to meet the demands of the pharmaceutical and chemical manufacturing value chain.
- Strategic Infrastructure: Manufacturing facilities equipped with advanced technology and strategically located for operational efficiency.
- Strong Client Relationships: Long-standing relationships with marquee clients across various sectors.
- Proven Growth Record: A consistent history of profitable growth and market leadership.
Bidding Starts In
Standard Glass Lining Technology IPO Specifics:
| IPO Date | January 6, 2025 to January 8, 2025 |
| Listing Date | Monday, January 13, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹133 to ₹140 per share |
| Lot Size | 107 Shares |
| Total Issue Size | 2,92,89,367 shares (aggregating up to ₹410.05 Cr) |
| Fresh Issue | 1,50,00,000 shares (aggregating up to ₹ 210.00 Cr) |
| Offer For Sale | 1,42,89,367 shares of ₹10 (aggregating up to ₹200.05 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 18,44,91,662 shares |
Standard Glass Lining Technology IPO Timetable (Important Dates)
| IPO Open Date | Monday, January 6, 2025 |
| IPO Close Date | Wednesday, January 8, 2025 |
| Basis of Allotment | Thursday, January 9, 2025 |
| Initiation of Refunds | Friday, January 10, 2025 |
| Credit of Shares to Demat | Friday, January 10, 2025 |
| Listing Date | Monday, January 13, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on January 8, 2025 |
Standard Glass Lining Technology IPO Lot Size
Bidders have the opportunity to bid for a minimum of 107 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 107 | ₹14,980 |
| Retail (Max) | 13 | 1,391 | ₹1,94,740 |
| S-HNI (Min) | 14 | 1,498 | ₹2,09,720 |
| S-HNI (Max) | 66 | 7,062 | ₹9,88,680 |
| B-HNI (Min) | 67 | 7,169 | ₹10,03,660 |
Standard Glass Lining Technology IPO Reservation
| QIB Shares Offered | Not more than 50% of the Net offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
Standard Glass Lining Technology Limited IPO Financial Information
Standard Glass Lining Technology Limited achieved a 10% increase in revenue and a 12% growth in profit after tax (PAT) during the financial year ended March 31, 2024, compared to the previous year ending March 31, 2023.
| Period Ended | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 30 Sep 2024 |
|---|---|---|---|---|
| Assets | 298.11 | 347.79 | 665.38 | 756.52 |
| Revenue | 241.5 | 500.08 | 549.68 | 312.1 |
| Profit After Tax | 25.15 | 53.42 | 60.01 | 36.27 |
| Net Worth | 69.91 | 156.67 | 409.92 | 447.8 |
| Reserves and Surplus | 53.66 | 139.94 | 389.18 | 261.58 |
| Total Borrowing | 69.81 | 81.96 | 129.32 | 173.8 |
Key Performance Indicator – Standard Glass Lining Technology IPO
| KPI | Values |
|---|---|
| EPS | ₹3.25 |
| P/E (x) | 43.04 |
| ROE | 20.74% |
| ROCE | 25.49% |
| Debt / Equity | 0.32 |
| RoNW | 20.74% |
Objects of the Issue:
The Company plans to utilize the Net Proceeds for the following purposes:
- Meeting capital expenditure requirements by purchasing machinery and equipment.
- Repaying or prepaying, fully or partially, certain outstanding borrowings of the Company and its wholly-owned subsidiary, S2 Engineering Industry Private Limited.
- Investing in S2 Engineering Industry Private Limited to support its capital expenditure needs, including the purchase of machinery and equipment.
- Supporting inorganic growth through strategic investments and acquisitions.
- Addressing general corporate expenses.
Prospectus Links:
Prospectus: Official documents that provide detailed information about the IPO and the company.
